Urinary symptoms in breast cancer: A systematic review

Cancer

Volumn 118, Issue 3, 2012, Pages 582-593

  Donovan, Kristine A ^a   Boyington, Alice R ^a   Ismail Khan, Roohi ^a   Wyman, Jean F ^b  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

breast cancer; menopause; survivorship; urogenital system

Indexed keywords

ANASTROZOLE; ANTINEOPLASTIC AGENT; AROMATASE INHIBITOR; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; GONADORELIN DERIVATIVE; METHOTREXATE; PLACEBO; TAMOXIFEN;

BLADDER DYSFUNCTION; BREAST CANCER; BREAST RECONSTRUCTION; BREAST SURGERY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER SURVIVOR; CHEMOPROPHYLAXIS; DISEASE SEVERITY; DRUG EFFICACY; EXTERNAL BEAM RADIOTHERAPY; HUMAN; MASTECTOMY; MENOPAUSAL SYNDROME; MICTURITION DISORDER; OVARIECTOMY; PARTIAL MASTECTOMY; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SYSTEMATIC REVIEW; URINARY TRACT DISEASE;

BREAST NEOPLASMS; FEMALE; HUMANS; MENOPAUSE; QUALITY OF LIFE; SURVIVORS; URINATION DISORDERS;

EID: 84856232097     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26324     Document Type: Review

References (53)

1. Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System Survey Questionnaire. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention; 2007.
2. American Cancer Society. Breast Cancer Facts & Figures 2007-2008. Atlanta, GA: American Cancer Society; 2007.
3. American Cancer Society. Cancer Facts & Figures 2008. Atlanta, GA: American Cancer Society; 2008.
4. Institute of Medicine and National Research. From Cancer Patient to Cancer Survivor: Lost in Transition. Washington, DC: National Academy of Sciences; 2006.
5. Ganz PA,. Menopause and breast cancer: symptoms, late effects, and their management. Semin in Oncol. 2001; 28: 274-283.
6. Lester JL, Bernhard LA,. Urogenital atrophy in breast cancer survivors. Oncol Nurs Forum. 2009; 36: 693-698.
7. Harris PF, Remington PL, Trentham-Dietz A, Allen CI, Newcomb PA,. Prevalence and treatment of menopausal symptoms among breast cancer survivors. J Pain Symptom Manage. 2002; 23: 501-509.
8. Smith IE, Dosett M,. Aromatase inhibitors in breast cancer. N Engl J Med. 2003; 348: 2431-2442.
9. Trinkaus M, Chin A, Wolfman W, Simmons C, Clemons M,. Should urogenital atrophy in breast cancer survivors be treated with topical estrogens? Oncologist. 2008; 13: 222-231.
10. Iosif CS, Bekassy Z,. Prevalence of genito-urinary symptoms in the late menopause. Acta Obstet Gynecol Scand. 1984; 63: 257-260.
11. Schaffer J, Fantl JA,. Urogenital effects of the menopause. Baillieres Clin Obstet Gynaecol. 1996; 10: 401-417.
12. Van Voorhis BJ,. Genitourinary symptoms in the menopausal transition. Am J Med 2005; 118 (suppl 12B): 47-53.
13. Iosif CS, Batra S, Edk A, Astedt B,. Estrogen receptors in the human female lower urinary tract. Am J Obstet Gynecol. 1981; 141: 817-820.
14. Saez S, Martin PM,. Evidence of estrogen receptors in the trigone area of human urinary bladder. J Steroid Biochem. 1981; 15: 317-320.
15. Batra SC, Iosif CS,. Progesterone receptors in the female lower urinary tract. J Urol. 1984; 138: 1301-1304.
16. Dew JE, Wren BG, Eden JA,. A cohort study of topical vaginal estrogen therapy in women previously treated for breast cancer. Climacteric. 2003; 6: 45-52.
17. Holroyd-Leduc JM, Tannenbaum C, Thorpe KE, Straus SE,. What type of urinary incontinence does this woman have? JAMA. 2008; 299: 1446-1456.
18. Wyman JF, Harkins SW, Choi SC, Taylor JR, Fantl JA,. Psychosocial impact of urinary incontinence in women. Obstet Gynecol. 1987; 70: 378-382.
19. Margalith I, Gillon G, Gordon D,. Urinary incontinence in women under 65: quality of life, stress related to incontinence and patterns of seeking health care. Qual Life Res. 2004; 13: 1381-1390.
20. Ragins AI, Shan J, Thom DH, Subak LL, Brown JS, Van Den Eeden SK,. Effects of urinary incontinence, comorbidity and race on quality of life outcomes in women. J Urol. 2008; 179: 651-655.
21. van der Vaart CH, de Leeuw JRJ, Roovers JWR, Heintz APM,. Measuring health-related quality of life in women with urogenital dysfunction: the Urogenital Distress Inventory and Incontinence Impact Questionnaire revisited. Neurourol Urodyn. 2003; 22: 97-104.
22. Paick J, Kim SW, Oh S, Ku JH,. A generic health-related quality of life instrument, the Medical Outcomes Study Short Form-36, in women with urinary incontinence. Eur J Obstet Gynecol. 2007; 130: 18-24.
23. Dougherty MC, Dwyer JW, Pendergast JF, et al. A randomized trial of behavioral management for continence with older rural women. Res Nurs Health. 2002; 25: 3-13.
24. Wyman JF,. Treatment of urinary incontinence in men and older women: the evidence shows the efficacy of a variety of techniques. Am J Nurs. 2003; suppl: 26-35.
25. Boyington AR, Dougherty MC, Phetrasuwan S,. Effectiveness of a computer-based system to deliver a continence health promotion intervention. J Wound Ostomy Continence Nurs. 2005; 32: 246-254.
26. Shamliyan TA, Kane RL, Wyman J, Wilt TJ,. Systematic review: randomized, controlled trials of nonsurgical treatments for urinary incontinence in women. Ann Intern Med. 2008; 148: 459-473.
27. Dugan E, Roberts C, Cohen S, et al. Why older community-dwelling adults do not discuss urinary incontinence with their primary care physicians. Am Geriatr Soc. 2001; 49: 462-465.
28. Hagglund D, Walker-Engstrom ML, Larsson G, Leppert J,. Quality of life and seeking help in women with urinary incontinence. Acta Obstet Gynecol Scand. 2001; 80: 1051-1055.
29. Koch LH,. Help-seeking behaviors of women with urinary incontinence: an integrative literature review [serial online]. J Midwifery Womens Health. 2006; 51: e39-e44.
30. Melville JL, Wagner LE, Fan M, Katon WJ, Newton KM,. Women's perceptions about the etiology of urinary incontinence. J Womens Health. 2008; 17: 1093-1098.
31. Couzi RJ, Helzlsouer KJ, Fetting JH,. Prevalence of menopausal symptoms among women with a history of breast cancer and attitudes toward estrogen replacement therapy. J Clin Oncol. 1995; 13: 2737-2744.
32. Ganz PA, Greendale GA, Petersen L, Zibecchi L, Kahn B, Belin TR,. Managing menopausal symptoms in breast cancer survivors: results of a randomized controlled trial. J Natl Cancer Inst. 2000; 92: 1054-1064.
33. Greendale GA, Petersen L, Zibecchi L, Ganz PA,. Factors related to sexual function in postmenopausal women with a history of breast cancer. Menopause. 2001; 8: 111-119.
34. Ganz PA, Desmond KA, Leedham B, Rowland JH, Meyerowitz BE, Belin TR,. Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study. J Natl Cancer Inst. 2002; 94: 39-49.
35. Ganz PA, Greendale GA, Petersen L, Kahn B, Bower JE,. Breast cancer in younger women: reproductive and late health effects of treatment. J Clin Oncol. 2003; 21: 4184-4193.
36. Avis NE, Crawford S, Manuel J,. Psychosocial problems among younger women with breast cancer. Psychooncology. 2004; 13: 295-308.
37. Land SR, Kopec JA, Yothers G, et al. Health-related quality of life in axillary node-negative, estrogen receptor-negative breast cancer patients undergoing AC versus CMF chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel Project B-23. Breast Cancer Res Treat. 2004; 86: 153-164.
38. Morales L, Neven P, Timmerman D, et al. Acute effects of tamoxifen and third-generation aromatase inhibitors on menopausal symptoms of breast cancer patients. Anticancer Drugs. 2004; 15: 753-760.
39. Oleske DM, Cobleigh MA, Phillips M, Nachman KL,. Determination of factors associated with hospitalization in breast cancer survivors. Oncol Nurs Forum. 2004; 31: 1081-1088.
40. Avis NE, Crawford S, Manuel J,. Quality of life among younger women with breast cancer. J Clin Oncol. 2005; 23: 3322-3330.
41. Stanton AL, Bernaards CA, Ganz PA,. The BCPT symptom scales: a measure of physical symptoms for women diagnosed with or at risk for breast cancer. J Natl Cancer Inst. 2005; 97: 448-456.
42. Alfano CM, McGregor BA, Kuniyuki A, et al. Psychometric properties of a tool for measuring hormone-related symptoms in breast cancer survivors. Psychooncology. 2006; 15: 985-1000.
43. Gupta P, Sturdee DW, Palin SL, et al. Menopausal symptoms in women treated for breast cancer: the prevalence and severity of symptoms and their perceived effects on quality of life. Climacteric. 2006; 9: 49-58.
44. Leining MG, Gelber S, Rosenberg R, Przypyszny M, Winer EP, Partridge AH,. Menopausal-type symptoms in young breast cancer survivors. Ann Oncol. 2006; 17: 1777-1782.
45. Schover LR, Jenkins R, Sui D, Adams JH, Marion MS, Jackson KE,. Randomized trial of peer counseling on reproductive health in African American breast cancer survivors. J Clin Oncol. 2006; 24: 1620-1626.
46. Chin SN, Trinkaus M, Simmons C, et al. Prevalence and severity of urogenital symptoms in postmenopausal women receiving endocrine therapy for breast cancer. Clin Breast Cancer. 2009; 9: 108-117.
47. Ganz PA, Day R, Wre JE Jr, Redmond C, Fisher B,. Baseline quality of life assessment in the National Surgical Adjuvant Brest and Bowel Project Brest Cancer Prevention Trial. J Natl Cancer Inst. 1995; 87: 1372-1382.
48. Landefeld CS, Bowers BJ, Feld AD, et al. National Institutes of Health state-of-the-science conference statement: prevention of fecal and urinary incontinence in adults. Ann Intern Med. 2008; 148: 449-458.
49. Altman D, Lapitan MC, Nelson R, Sillen U, Thom D,. Epidemiology of urinary (UI) and faecal (FI) incontinence and pelvic organ prolapse (POP). In:, Abrams P, Cardozo L, Khoury S, Wein A, eds. Incontinence: Proceedings from the Fourth International Consultation on Incontinence (Paris, France). Plymouth, United Kingdom: Health Publication Ltd, 2009: 35-111.
50. Staskin D, Kelleher C, Bosch R, et al. Patient-oriented assessment. In:, Abrams P, Cardozo L, Khoury S, Wein A, eds. Incontinence: Proceedings from the Fourth International Consultation on Incontinence (Paris, France). Plymouth, United Kingdom: Health Publications Ltd.; 2009: 363-412.
51. Kincade JE, Dougherty MC, Carlson JR, Hunter GS, Busby-Whitehead J,. Randomized clinical trial of efficacy of self-monitoring techniques to treat urinary incontinence in women. Neurourol Urodyn. 2007; 26: 507-511.
52. Dumoulin C, Hay-Smith J,. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database Syst Rev. 2010; (1): CD005654.
53. Haylen BT, de Ridder D, Freeman RM, et al. An International Urogynecological Association (IUGA/International Incontinence Society [ICS]) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. 2009; 29: 4-20.